zaleplon

za-LEP-lon

Therapeutic Classification: sedative/hypnotics

BEERS REMS

Short-term management of insomnia in patients unable to get ≥4 hr of sleep; especially useful in sleep initiation disorders.

Produces CNS depression by binding to GABA receptors in the CNS.
Has no analgesic properties.

Therapeutic effects:

Induction of sleep.

Absorption: Rapidly absorbed following oral administration.

Distribution: Well distributed to tissues.

Metabolism/Excretion: Extensively metabolized in the liver (mostly by aldehyde oxidase and some by the CYP3A4 isoenzyme).

Half-Life: 1 hr.

ROUTE	ONSET	PEAK	DURATION
PO	within min	unknown	3–4 hr

Contraindicated in:

Hypersensitivity;
History of experiencing complex sleep behaviors with zaleplon;
Severe hepatic impairment;
OB: Pregnancy;
Lactation: Lactation.

Use Cautiously in:

Mild or moderate hepatic impairment or weight ≤50 kg (initiate therapy at lowest dose);
Impaired respiratory function;
History of suicide attempt;
Pedi: Safety and effectiveness not established in children;
Geri: Appears on Beers list. ↑ risk of cognitive impairment, delirium, falls, fractures, and motor vehicle accidents in older adults. Avoid use in older adults.

CV: peripheral edema

Derm: photosensitivity

EENT: abnormal vision, altered sense of smell, ear pain, epistaxis, hearing sensitivity, ocular pain

GI: abdominal pain, anorexia, colitis, dyspepsia, nausea

GU: dysmenorrhea

Neuro: abnormal thinking, amnesia, anxiety, behavior changes, COMPLEX SLEEP BEHAVIORS (INCLUDING SLEEP DRIVING, SLEEP WALKING, OR ENGAGING IN OTHER ACTIVITIES WHILE SLEEPING), depersonalization, dizziness, drowsiness, hallucinations, headache, hyperesthesia, impaired memory (briefly following dose), impaired psychomotor function (briefly following dose), malaise, nightmares, paresthesia, tremor, vertigo, weakness

Misc: fever

Drug-drug:

Cimetidine may ↑ levels and risk of toxicity; initiate therapy at a lower dose.
Additive CNS depression with other CNS depressants, including alcohol, antihistamines, opioid analgesics, other sedative/hypnotics, phenothiazines, and tricyclic antidepressants.
CYP3A4 inducers, including rifampin, phenytoin, carbamazepine, and phenobarbital, may ↓ levels and effectiveness.

Drug-Natural Products:

Kava-kava, valerian, chamomile, or hops can ↑ risk of CNS depression.

Drug-Food:

Concurrent ingestion of a high-fat meal slows the rate of absorption.

PO (Adults <65 yr): 10 mg (range 5–20 mg) at bedtime.

Hepatic Impairment

PO (Adults ): Initiate therapy at 5 mg at bedtime (not to exceed 10 mg at bedtime).

(Generic available)

Capsules: 5 mg; 10 mg

Assess mental status, sleep patterns, and potential for abuse prior to administering this medication. Zaleplon is used to treat short-term difficulty in falling asleep; ↓ time to sleep onset. May not ↑ total sleep time or ↓ number of wakenings after falling asleep. Prolonged use of >7–10 days may lead to physical and psychological dependence. Limit amount of drug available to the patient.
Assess patient for pain and medicate as needed. Untreated pain ↓ sedative effect.
Assess for complex sleep behaviors (sleep-walking, sleep-driving, or engaging in activities while not fully awake). May cause serious injuries and even death; if these behaviors occur, discontinue immediately if identified.

Do not confuse Sonata with Soriatane.
Before administering, reduce external stimuli and provide comfort measures to ↑ effectiveness.
- Protect patient from injury. Supervise ambulation and transfer of patient after administration. Remove any cigarettes. Side rails should be raised and call bell within reach at all times.
PO: DNC: Tablets should be swallowed whole with full glass of water immediately before bedtime or after going to bed and experiencing difficulty falling asleep. Do not administer with or immediately after a high-fat or heavy meal.

Explain purpose and side effects of medication. Advise patient to read Patient Information before starting therapy.
Instruct patient not to take more than the amount prescribed because of the habit-forming potential. Not recommended for use longer than 7–10 days. Rebound insomnia (1–2 nights) may occur when stopped. If used for ≥2 wk, abrupt withdrawal may result in dysphoria, insomnia, abdominal or muscle cramps, vomiting, sweating, tremors, and seizures.
Because of rapid onset, advise patient to go to bed immediately after taking zaleplon.
May cause daytime drowsiness or dizziness. Advise patient to avoid driving or other activities requiring alertness until response to this medication is known.
Inform patient that amnesia may occur, but can be avoided if only taken when they can get >4 hr sleep.
Caution patient that complex sleep-related behaviors (sleep-driving, making phone calls, preparing and eating food, having sex, sleep walking) may occur while asleep. Inform patient to notify health care provider if sleep-related behaviors (may include sleep-driving: driving while not fully awake after ingestion of a sedative-hypnotic product, with no memory of the event) occur.
Advise patient to notify health care provider of all Rx or OTC medications, vitamins, or herbal products being taken and to consult health care provider before taking other medications.
Caution patient to avoid concurrent use of alcohol or other CNS depressants, including opioids.
Rep: May cause fetal harm. Use is not recommended during pregnancy or breastfeeding. Advise women of reproductive potential to notify health care provider if pregnancy is planned or suspected or if breastfeeding.

Improved ability to fall asleep; ↓ time to sleep onset.

~~Sonata~~

Schedule IV (C-IV)

NDC Code

0054- Hikma Pharmaceuticals USA Inc.
- 0054-0084- Zaleplon
  - 0054-0084-25- 100 CAPSULE in 1 BOTTLE (0054-0084-25)

0054- Hikma Pharmaceuticals USA Inc.
- 0054-0085- Zaleplon
  - 0054-0085-25- 100 CAPSULE in 1 BOTTLE (0054-0085-25)

29300- Unichem Pharmaceuticals (USA), Inc.
- 29300-131- zaleplon
  - 29300-131-01- 100 CAPSULE in 1 BOTTLE, PLASTIC (29300-131-01)

29300- Unichem Pharmaceuticals (USA), Inc.
- 29300-131- zaleplon
  - 29300-131-05- 500 CAPSULE in 1 BOTTLE, PLASTIC (29300-131-05)

29300- Unichem Pharmaceuticals (USA), Inc.
- 29300-131- zaleplon
  - 29300-131-13- 30 CAPSULE in 1 BOTTLE, PLASTIC (29300-131-13)

29300- Unichem Pharmaceuticals (USA), Inc.
- 29300-132- zaleplon
  - 29300-132-01- 100 CAPSULE in 1 BOTTLE, PLASTIC (29300-132-01)

29300- Unichem Pharmaceuticals (USA), Inc.
- 29300-132- zaleplon
  - 29300-132-05- 500 CAPSULE in 1 BOTTLE, PLASTIC (29300-132-05)

29300- Unichem Pharmaceuticals (USA), Inc.
- 29300-132- zaleplon
  - 29300-132-10- 1000 CAPSULE in 1 BOTTLE, PLASTIC (29300-132-10)

43063- PD-Rx Pharmaceuticals, Inc.
- 43063-505- ZALEPLON
  - 43063-505-30- 30 CAPSULE in 1 BOTTLE, PLASTIC (43063-505-30)

43063- PD-Rx Pharmaceuticals, Inc.
- 43063-783- zaleplon
  - 43063-783-10- 10 CAPSULE in 1 BOTTLE, PLASTIC (43063-783-10)

43063- PD-Rx Pharmaceuticals, Inc.
- 43063-912- Zaleplon
  - 43063-912-10- 10 CAPSULE in 1 BOTTLE, PLASTIC (43063-912-10)

50090- A-S Medication Solutions
- 50090-1564- zaleplon
  - 50090-1564-0- 10 CAPSULE in 1 BOTTLE (50090-1564-0)

50090- A-S Medication Solutions
- 50090-1564- zaleplon
  - 50090-1564-1- 30 CAPSULE in 1 BOTTLE (50090-1564-1)

51846- Teva Pharmaceutical Works Private Limited Company
- 51846-1026-
  - 51846-1026-0- 5 kg in 1 CARTON (51846-1026-0)

52562- Chromo Laboratories India Private Limited
- 52562-017-
  - 52562-017-01- 50 kg in 1 CONTAINER (52562-017-01)

57237- Rising Pharma Holdings, Inc.
- 57237-239- ZALEPLON
  - 57237-239-01- 100 CAPSULE in 1 BOTTLE (57237-239-01)

57237- Rising Pharma Holdings, Inc.
- 57237-240- ZALEPLON
  - 57237-240-01- 100 CAPSULE in 1 BOTTLE (57237-240-01)

63629- Bryant Ranch Prepack
- 63629-3405- zaleplon
  - 63629-3405-1- 15 CAPSULE in 1 BOTTLE (63629-3405-1)

63629- Bryant Ranch Prepack
- 63629-3405- zaleplon
  - 63629-3405-2- 30 CAPSULE in 1 BOTTLE (63629-3405-2)

63629- Bryant Ranch Prepack
- 63629-3405- zaleplon
  - 63629-3405-3- 60 CAPSULE in 1 BOTTLE (63629-3405-3)

63629- Bryant Ranch Prepack
- 63629-3405- zaleplon
  - 63629-3405-4- 90 CAPSULE in 1 BOTTLE (63629-3405-4)

64330- Centaur Pharmaceuticals Private Limited
- 64330-054-
  - 64330-054-07- 5 kg in 1 DRUM (64330-054-07)

64330- Centaur Pharmaceuticals Private Limited
- 64330-054-
  64330-054-12- 10 kg in 1 DRUM (64330-054-12)

64330- Centaur Pharmaceuticals Private Limited
- 64330-054-
  64330-054-15- 25 kg in 1 DRUM (64330-054-15)

64330- Centaur Pharmaceuticals Private Limited
- 64330-054-
  64330-054-27- 2.7 kg in 1 DRUM (64330-054-27)

64330- Centaur Pharmaceuticals Private Limited
- 64330-054-
  64330-054-28- 2.15 kg in 1 DRUM (64330-054-28)

64330- Centaur Pharmaceuticals Private Limited
- 64330-054-
  64330-054-29- 29.7 kg in 1 DRUM (64330-054-29)

64330- Centaur Pharmaceuticals Private Limited
- 64330-054-
  64330-054-30- 24 kg in 1 DRUM (64330-054-30)

64330- Centaur Pharmaceuticals Private Limited
- 64330-054-
  64330-054-31- 24.5 kg in 1 DRUM (64330-054-31)

64330- Centaur Pharmaceuticals Private Limited
- 64330-054-
  64330-054-32- 1.5 kg in 1 DRUM (64330-054-32)

64330- Centaur Pharmaceuticals Private Limited
- 64330-054-
  64330-054-33- 28 kg in 1 DRUM (64330-054-33)

64330- Centaur Pharmaceuticals Private Limited
- 64330-054-
  64330-054-34- 17.5 kg in 1 DRUM (64330-054-34)

64330- Centaur Pharmaceuticals Private Limited
- 64330-054-
  64330-054-35- 18 kg in 1 DRUM (64330-054-35)

64330- Centaur Pharmaceuticals Private Limited
- 64330-054-
  64330-054-36- 16 kg in 1 DRUM (64330-054-36)

64330- Centaur Pharmaceuticals Private Limited
- 64330-054-
  64330-054-37- 18.5 kg in 1 DRUM (64330-054-37)

64330- Centaur Pharmaceuticals Private Limited
- 64330-054-
  64330-054-38- 28.5 kg in 1 DRUM (64330-054-38)

64330- Centaur Pharmaceuticals Private Limited
- 64330-054-
  64330-054-39- 29 kg in 1 DRUM (64330-054-39)

64330- Centaur Pharmaceuticals Private Limited
- 64330-054-
  64330-054-40- 7 kg in 1 DRUM (64330-054-40)

64330- Centaur Pharmaceuticals Private Limited
- 64330-054-
  64330-054-41- 19 kg in 1 DRUM (64330-054-41)

64330- Centaur Pharmaceuticals Private Limited
- 64330-054-
  64330-054-42- 20 kg in 1 DRUM (64330-054-42)

64330- Centaur Pharmaceuticals Private Limited
- 64330-054-
  64330-054-43- 19.5 kg in 1 DRUM (64330-054-43)

64330- Centaur Pharmaceuticals Private Limited
- 64330-054-
  64330-054-44- 27 kg in 1 DRUM (64330-054-44)

64330- Centaur Pharmaceuticals Private Limited
- 64330-054-
  64330-054-45- 23 kg in 1 DRUM (64330-054-45)

65862- Aurobindo Pharma Limited
- 65862-197-
  65862-197-37- 50 kg in 1 DRUM (65862-197-37)

65862- Aurobindo Pharma Limited
- 65862-214- ZALEPLON
  65862-214-01- 100 CAPSULE in 1 BOTTLE (65862-214-01)

65862- Aurobindo Pharma Limited
- 65862-214- ZALEPLON
  - 65862-214-05- 500 CAPSULE in 1 BOTTLE (65862-214-05)

65862- Aurobindo Pharma Limited
- 65862-214-
  - 65862-214-26- 2500 CAPSULE in 1 BAG (65862-214-26)

65862- Aurobindo Pharma Limited
- 65862-215- ZALEPLON
  65862-215-01- 100 CAPSULE in 1 BOTTLE (65862-215-01)

65862- Aurobindo Pharma Limited
- 65862-215- ZALEPLON
  - 65862-215-05- 500 CAPSULE in 1 BOTTLE (65862-215-05)

65862- Aurobindo Pharma Limited
- 65862-215-
  - 65862-215-26- 2500 CAPSULE in 1 BAG (65862-215-26)

68788- Preferred Pharmaceuticals Inc.
- 68788-7208- zaleplon
  68788-7208-1- 100 CAPSULE in 1 BOTTLE, PLASTIC (68788-7208-1)

68788- Preferred Pharmaceuticals Inc.
- 68788-7208- zaleplon
  - 68788-7208-2- 20 CAPSULE in 1 BOTTLE, PLASTIC (68788-7208-2)

68788- Preferred Pharmaceuticals Inc.
- 68788-7208- zaleplon
  - 68788-7208-3- 30 CAPSULE in 1 BOTTLE, PLASTIC (68788-7208-3)

68788- Preferred Pharmaceuticals Inc.
- 68788-7208- zaleplon
  - 68788-7208-6- 60 CAPSULE in 1 BOTTLE, PLASTIC (68788-7208-6)

68788- Preferred Pharmaceuticals Inc.
- 68788-7208- zaleplon
  - 68788-7208-9- 90 CAPSULE in 1 BOTTLE, PLASTIC (68788-7208-9)

68788- Preferred Pharmaceuticals Inc.
- 68788-8725- Zaleplon
  - 68788-8725-1- 100 CAPSULE in 1 BOTTLE (68788-8725-1)

68788- Preferred Pharmaceuticals Inc.
- 68788-8725- Zaleplon
  - 68788-8725-2- 20 CAPSULE in 1 BOTTLE (68788-8725-2)

68788- Preferred Pharmaceuticals Inc.
- 68788-8725- Zaleplon
  - 68788-8725-3- 30 CAPSULE in 1 BOTTLE (68788-8725-3)

68788- Preferred Pharmaceuticals Inc.
- 68788-8725- Zaleplon
  - 68788-8725-6- 60 CAPSULE in 1 BOTTLE (68788-8725-6)

68788- Preferred Pharmaceuticals Inc.
- 68788-8725- Zaleplon
  - 68788-8725-9- 90 CAPSULE in 1 BOTTLE (68788-8725-9)

69452- Bionpharma Inc.
- 69452-364- Zaleplon
  - 69452-364-20- 100 CAPSULE in 1 BOTTLE (69452-364-20)

69452- Bionpharma Inc.
- 69452-365- Zaleplon
  - 69452-365-20- 100 CAPSULE in 1 BOTTLE (69452-365-20)

71335- Bryant Ranch Prepack
- 71335-0236- zaleplon
  - 71335-0236-1- 30 CAPSULE in 1 BOTTLE (71335-0236-1)

71335- Bryant Ranch Prepack
- 71335-0236- zaleplon
  - 71335-0236-2- 60 CAPSULE in 1 BOTTLE (71335-0236-2)

71335- Bryant Ranch Prepack
- 71335-0236- zaleplon
  - 71335-0236-3- 90 CAPSULE in 1 BOTTLE (71335-0236-3)

71335- Bryant Ranch Prepack
- 71335-0236- zaleplon
  - 71335-0236-4- 20 CAPSULE in 1 BOTTLE (71335-0236-4)

71335- Bryant Ranch Prepack
- 71335-0236- zaleplon
  - 71335-0236-5- 28 CAPSULE in 1 BOTTLE (71335-0236-5)

71335- Bryant Ranch Prepack
- 71335-1054- ZALEPLON
  - 71335-1054-1- 15 CAPSULE in 1 BOTTLE (71335-1054-1)

71335- Bryant Ranch Prepack
- 71335-1054- ZALEPLON
  - 71335-1054-2- 30 CAPSULE in 1 BOTTLE (71335-1054-2)

71335- Bryant Ranch Prepack
- 71335-1054- ZALEPLON
  - 71335-1054-3- 60 CAPSULE in 1 BOTTLE (71335-1054-3)

71335- Bryant Ranch Prepack
- 71335-1054- ZALEPLON
  - 71335-1054-4- 90 CAPSULE in 1 BOTTLE (71335-1054-4)

71335- Bryant Ranch Prepack
- 71335-2468- Zaleplon
  - 71335-2468-1- 15 CAPSULE in 1 BOTTLE (71335-2468-1)

71335- Bryant Ranch Prepack
- 71335-2468- Zaleplon
  - 71335-2468-2- 30 CAPSULE in 1 BOTTLE (71335-2468-2)

71335- Bryant Ranch Prepack
- 71335-2468- Zaleplon
  - 71335-2468-3- 60 CAPSULE in 1 BOTTLE (71335-2468-3)

71335- Bryant Ranch Prepack
- 71335-2468- Zaleplon
  - 71335-2468-4- 90 CAPSULE in 1 BOTTLE (71335-2468-4)

84671- TAPI Hungary Industries Kft.
- 84671-1026-
  - 84671-1026-0- 5 kg in 1 CARTON (84671-1026-0)

section name header

Pronunciation ⬇

Classifications ⬆ ⬇

Indications ⬆ ⬇

Action ⬆ ⬇

Pharmacokinetics ⬆ ⬇

Time/Action Profile ⬆ ⬇

Contraind./Precautions ⬆ ⬇

Adv. Reactions/Side Effects ⬆ ⬇

Interactions ⬆ ⬇

Route/Dosage ⬆ ⬇

Availability ⬆ ⬇

Assessment ⬆ ⬇

Implementation ⬆ ⬇

Patient/Family Teaching ⬆ ⬇

Evaluation/Desired Outcomes ⬆ ⬇

US Brand Names ⬆ ⬇

Contr. Subst. Schedule ⬆ ⬇

Code ⬆